Before you sell to, join or invest in Fedora Pharmaceuticals Inc.
MentionFox check on Fedora Pharmaceuticals Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/fedora-pharmaceuticals-inc-form-d-25000001
Check Fedora Pharmaceuticals Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Fedora Pharmaceuticals Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Fedora Pharmaceuticals Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-06.
Fedora Pharmaceuticals Inc. filed a Form D notice of an exempt securities offering with the SEC on June 6, 2025. The filing reports $895K sold. Its industry group is Pharmaceuticals. It names Christopher Micetich (Executive Officer, Director), Leonard Post (Director), Sarat Maharaj (Director) (SEC Form D, June 6, 2025).
Is this your company?
Sell to companies like Fedora Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Fedora Pharmaceuticals Inc.
Free to see. No signup.
More on the people and the money behind Fedora Pharmaceuticals Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Fedora Pharmaceuticals Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Fedora Pharmaceuticals Inc. raises, hires or launches. No email unless you switch it on.
Watch Fedora Pharmaceuticals Inc. →Get the full cited report on Fedora Pharmaceuticals Inc.
What the filing shows about Fedora Pharmaceuticals Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Fedora Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Fedora Pharmaceuticals Inc.'s address as 11629 105 Avenue Nw, Edmonton, A0 T5H 092.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Fedora Pharmaceuticals Inc. See pricing
Fedora Pharmaceuticals Inc. is a registered filer with the SEC (CIK 1576423) and has filed since 2025-06-06. 1 filing is on record, the latest on 2025-06-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Fedora Pharmaceuticals Inc.'s Form D of 2025-06-06 names Christopher Micetich, Leonard Post and Sarat Maharaj as its officers, directors or promoters.
Its new offerings report $895K sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Fedora Pharmaceuticals is a clinical-stage biotech developing new antibiotics against multi-drug-resistant bacteria. Lead asset Nacubactam is a Phase 3-ready beta-lactamase inhibitor. Partnering and licensing open.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Christopher Micetich is named as Executive Officer and Director on the Form D that Fedora Pharmaceuticals Inc. filed with the SEC on 6 June 2025, one of 3 people that filing names.
Leonard Post is named as Director on the Form D that Fedora Pharmaceuticals Inc. filed with the SEC on 6 June 2025, one of 3 people that filing names.
Sarat Maharaj is named as Director on the Form D that Fedora Pharmaceuticals Inc. filed with the SEC on 6 June 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-06-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Fedora Pharmaceuticals Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Fedora Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fedora Pharmaceuticals Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Fedora Pharmaceuticals Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Fedora Pharmaceuticals Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (fedorapharma.com).
Each opens in a new tab, filled in for Fedora Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/fedora-pharmaceuticals-inc-form-d-25000001